Vomaris and Metrex™ Announce Exclusive Distribution Agreement for Procellera® Technology in Long Term Care Market

Sep 15, 2015, 06:00 ET from Vomaris Innovations, Inc.

TEMPE, Ariz., Sept. 15, 2015 /PRNewswire/ -- Vomaris Innovations, Inc. announced today that it has entered into an exclusive global commercial partnership for its microcurrent generating wound care products, Procellera® Antimicrobial Wound Dressings, for the Long Term Care market with Metrex, a professional consumables brand within Kavo Kerr Group, which is a member of the Danaher Corporation.

Metrex is the only company offering a system of solutions designed to address cross-contamination across the entire healthcare facility. Their exclusive Infection Prevention's Circle of Care™ represents the seven most critical areas in the healthcare environment in preventing healthcare-associated infections (HAIs). With the addition of Procellera Technology to their product portfolio they are now able to provide an important infection prevention solution for the body.

"The growing patient population, escalating threat of resistant microbes and demand to minimize risk of HAIs makes the Long Term Care segment very important to us. As a result of our partnership with Metrex, we will be able to reduce infection risk and support wound healing for more patients than ever before. Importantly, with Procellera Technology we are able to do this with a cost effective non-pharmacologic solution," commented Michael Nagel, President and CEO of Vomaris Innovations, Inc.

Advanced Microcurrent TechnologyTM is the only platform in the world that powers a new generation dressing solution for wound and incisional care.  It creates an optimal environment for wound healing with demonstrated efficacy against a broad-spectrum of microbes including drug-resistant1 and biofilm-forming pathogens2, and the ability to enhance cellular migration3.

Nursing homes, skilled nursing facilities, and assisted living facilities, collectively referred to as long-term care facilities or LTCFs present a significant wound management challenge, making prevention of infectious complications a major priority. According to the CDC, over 3 million Americans receive care in U.S. nursing homes and skilled nursing facilities annually and nearly one million persons reside in assisted living facilities. One to three million serious infections occur every year in these facilities, making them a major cause of hospitalization and death, and as many as 380,000 people die of infections in LTCFs every year.

"We are very excited about this partnership," said Metrex General Manager, Steve Fanning. "As a leader in Infection Prevention, we believe Procellera will allow us to broaden our portfolio of products to help prevent HAIs throughout Infection Prevention's Circle of Care."

Under the terms of this distribution agreement, Metrex will have exclusive global distribution rights to Procellera Technology in the Long Term Care Market. Vomaris will have continued responsibility for manufacturing and ongoing research and development.

About Vomaris Innovations

Vomaris Innovations, Inc. is a privately held company specializing in electroceutical solutions for the wound care market and beyond. Utilizing electricity to mimic the body's physiologic electric currents, which are essential for skin repair and wound healing, Vomaris' core technology platform, Procellera Technology, employs embedded microcell batteries that generate microcurrents to reduce infection risk1-2 and enhance healing3. Procellera is currently used in multiple acute and chronic wound care settings, including clinical, animal and consumer health.

About Metrex

Metrex is the only company that offers a system of solutions designed to address cross contamination across the entire healthcare facility. The company's headquarters is located in Orange, CA. Metrex also has a manufacturing facility in Romulus, MI. To learn more about the Circle of Care and other infection prevention best practices, please call 800-841-1428, or visit www.metrex.com.

References

(1) Kim H et al. Antibacterial Efficacy Testing of a Bioelectric Wound Dressing Against Clinical Wound Pathogens.  The Open Microbiology Journal 2014; 8:15-21.   (2) Banerjee J et al. (2015) Silver-Zinc Redox-Coupled Electroceutical Wound Dressing Disrupts Bacterial Biofilm. PLoS ONE 10(3): e0119531. doi:10.1371/journal.pone.0119531.   (3) Banerjee J et al. (2014) Improvement of Human Keratinocyte Migration by a Redox Active Bioelectric Dressing. PLoS ONE 9(3): e89239. doi:10.1371/journal.pone.0089239

MKT-1082

 

SOURCE Vomaris Innovations, Inc.